T V Dubinina - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Terapevticheskii Arkhiv|June 30, 2020

[Spondyloarthritis: modern terminology and definitions]S F Erdes, A P Rebrov, T V Dubinina, et al.

Terapevticheskii Arkhiv|April 16, 2025

[Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases]G V Lukina, O V Knyazev, E A Belousova, et al.

Doklady. Biochemistry and Biophysics|May 12, 2025

The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTAE L Nasonov, V I Mazurov, A M Lila, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Terapevticheskii Arkhiv|June 30, 2020

[Spondyloarthritis: modern terminology and definitions]S F Erdes, A P Rebrov, T V Dubinina, et al.

Terapevticheskii Arkhiv|April 16, 2025

[Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases]G V Lukina, O V Knyazev, E A Belousova, et al.

Doklady. Biochemistry and Biophysics|May 12, 2025

The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTAE L Nasonov, V I Mazurov, A M Lila, et al.

Pageof 2